Pierre Legault Net Worth

The estimated Net Worth of Pierre Legault is at least $901 mil dollars as of 12 January 2023. Mr. Legault owns over 39,000 units of Syndax Pharmaceuticals Inc stock worth over $677,840 and over the last 18 years he sold SNDX stock worth over $0. In addition, he makes $223,246 as Independent Director at Syndax Pharmaceuticals Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Legault SNDX stock SEC Form 4 insiders trading

Pierre has made over 9 trades of the Syndax Pharmaceuticals Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 39,000 units of SNDX stock worth $430,950 on 12 January 2023.

The largest trade he's ever made was exercising 150,000 units of Syndax Pharmaceuticals Inc stock on 20 December 2021 worth over $1,269,000. On average, Pierre trades about 7,744 units every 17 days since 2007. As of 12 January 2023 he still owns at least 37,000 units of Syndax Pharmaceuticals Inc stock.

You can see the complete history of Mr. Legault stock trades at the bottom of the page.

Pierre Legault biography

Pierre Legault CPA serves as Independent Director of the Company. Mr. Legault also serves on the board of Artios Pharma (Chairman), Bicycle Therapeutics (Chairman), Poxel Pharmaceuticals (Chairman), Clementia Pharmaceuticals and Urovant Sciences. Previously, he served on the board of Armo BioSciences, Iroko Pharmaceuticals, Tobira Therapeutics, NPS Pharmaceuticals, Forest Laboratories, Cyclacel Pharmaceuticals, Eckerd Pharmacy, Regado Biosciences, NephroGenex and several others. Mr. Legault served as Chairman of NephroGenex, a biopharmaceutical company, from 2012 through 2013, and as Chief Executive Officer from 2014 through 2016, as Chief Executive Officer of Prosidion from 2010 through 2012, and Executive Vice President, Chief Financial Officer, and Treasurer of OSI Pharmaceuticals from 2009 through 2010. His prior senior executive experience also includes serving as President of Eckerd Pharmacy and as Executive Vice President and Chief Administrative Officer of Rite Aid Corporation. He also held several senior positions with Sanofi-Aventis and predecessor companies, including President of Worldwide Dermatology Operations. Mr. Legault studied at McGill University, HEC Montreal and Harvard Business School. He holds an M.B.A., BAA, CA, CPA and Six Sigma Green Belt diplomas.

What is the salary of Pierre Legault?

As the Independent Director of Syndax Pharmaceuticals Inc, the total compensation of Pierre Legault at Syndax Pharmaceuticals Inc is $223,246. There are 6 executives at Syndax Pharmaceuticals Inc getting paid more, with Michael Metzger having the highest compensation of $2,696,890.

How old is Pierre Legault?

Pierre Legault is 59, he's been the Independent Director of Syndax Pharmaceuticals Inc since 2017. There are 6 older and 11 younger executives at Syndax Pharmaceuticals Inc. The oldest executive at Syndax Pharmaceuticals Inc is Dr. Michael L. Meyers M.D., Ph.D., 70, who is the Chief Medical Officer & Sr. VP.

What's Pierre Legault's mailing address?

Pierre's mailing address filed with the SEC is C/O SYNDAX PHARMACEUTICALS, INC., 35 GATEHOUSE DRIVE, BUILDING D, FLOOR 3, WALTHAM, MA, 02451.

Insiders trading at Syndax Pharmaceuticals Inc

Over the last 9 years, insiders at Syndax Pharmaceuticals Inc have traded over $1,950,406 worth of Syndax Pharmaceuticals Inc stock and bought 210,921 units worth $2,347,816 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Luke Evnin y Briggs Morrison. On average, Syndax Pharmaceuticals Inc executives and independent directors trade stock every 50 days with the average trade being worth of $745,679. The most recent stock trade was executed by Keith A. Goldan on 14 June 2024, trading 1,250 units of SNDX stock currently worth $25,038.

What does Syndax Pharmaceuticals Inc do?

syndax pharmaceuticals is a biotechnology company located at 35 gatehouse dr., building d, floor 3, waltham, ma 02451.

Complete history of Mr. Legault stock trades at Cyclacel Pharmaceuticals Inc, Syndax Pharmaceuticals Inc, Rite Aid, Urovant Sciences Ltd y Bicycle Therapeutics plc

Syndax Pharmaceuticals Inc executives and stock owners

Syndax Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

• Michael Metzger,
  President, Chief Operating Officer, Director
• Briggs Morrison,
  Chief Executive Officer, Director
• Dr. Briggs W. Morrison M.D.,
  CEO & Director
• Michael A. Metzger M.B.A.,
  Pres, COO & Director
• Michael Meyers,
  Senior Vice President, Chief Medical Officer
• Dennis Podlesak,
  Independent Chairman of the Board
• Pierre Legault,
  Independent Director
• Keith Katkin,
  Independent Director
• William Meury,
  Independent Director
• Fabrice Egros,
  Independent Director
• Jennifer Jarrett,
  Independent Director
• Peter Ordentlich,
  Chief Scientific Officer
• Luke Albrecht,
  Senior Vice President, General Counsel, Secretary
• Daphne Karydas,
  Chief Financial Officer, Principal Financial Officer, Principal Accounting Officer, Treasurer
• Dr. Edward A. Sausville M.D., Ph.D.,
  Advisor
• Dr. Michael L. Meyers M.D., Ph.D.,
  Chief Medical Officer & Sr. VP
• Luke J. Albrecht,
  Sr. VP, Gen. Counsel & Sec.
• Alexander Nolte,
  Interim Principal Financial Officer, VP & Chief Accounting Officer
• Dr. Michael Downes Ph.D.,
  Co-Founder
• Dr. Ronald M. Evans Ph.D.,
  Co-Founder, Advisor and Chair of Scientific Advisory Board
• Dr. Richard A. Heyman Ph.D.,
  Co-Founder
• Dr. Peter Ordentlich B.Sc., Ph.D.,
  Co-Founder & Chief Scientific Officer
• Martin H. Jr. Huber,
  
• Neil Gallagher,
  President, Head of R&D
• Luke Evnin,
  Director
• Henry Chen,
  
• Partners L P/Ilbiotechnolog...,
  
• Steve M Sabus,
  Chief Commercial Officer
• Ivor Royston,
  Director
• Viii Associates, L.P.Blair ...,
  
• Vi Associates, L.P.Blair Ja...,
  
• Partners Vi, L.P.Blair Jame...,
  
• George W. Jr. Sledge,
  
• Bio Ventures Iv Qp Lp Scopa...,
  
• Partners Viii, L.P.Blair Ja...,
  
• Kim P. Kamdar,
  Director
• Richard P Shea,
  Chief Financial Officer
• Alexander Nolte,
  Chief Accounting Officer
• Catherine Madigan,
  Chief Medical Officer
• Keith A. Goldan,
  Chief Financial Officer